Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05923229 · ClinicalTrials.gov registry record · NA

Moving Mindfully for Freezing of Gait

A NA study of Parkinson Disease and Mindfulness, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT05923229: Completed NA study of Parkinson Disease and Mindfulness, sponsored by Washington University School of Medicine.

NCT05923229 is a NA study of Parkinson Disease and Mindfulness that has completed, run by Washington University School of Medicine. The registered enrollment target is 24 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05923229, a NA study of Parkinson Disease and Mindfulness, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The investigators will conduct an randomized controlled trial (RCT) among people with Parkinson disease (PD) and freezing of gait (FOG) to evaluate the feasibility of a mindfulness intervention compared to a educational program about FOG. FOG is a severe motor disturbance that prevents people from stepping normally and is associated with anxiety, frustration, sedentary behaviors, poorer quality of life, and falls. Mindfulness-Based Stress Reduction (MBSR) is an evidence-based practice that creates a culture to reduce stress and anxiety by increasing conscious awareness and self-compassion. In this study, the investigators will develop a mindfulness-based walking intervention to address both mental health and mobility challenges that constitute FOG.

Primary Outcome

The investigators will count the number of participants recruited to determine if the feasibility objective of recruitment is met. The investigators benchmark for recruitment is defined as recruiting a target sample of 24 participants to randomize.

Interventions

  • BEHAVIORAL Mindfulness Based Walking Therapy (MBWT)
  • OTHER Freezing of Gait (FOG) Education

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2023-06-07
Est. Completion 2024-04-26
Phase NA

What the finished NCT05923229 record still lists

NCT05923229 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Based Walking Therapy (MBWT) is the first listed.

NCT05923229 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05923229 about?

NCT05923229 is a clinical study titled "Moving Mindfully for Freezing of Gait". The investigators will conduct an randomized controlled trial (RCT) among people with Parkinson disease (PD) and freezing of gait (FOG) to evaluate the feasibility of a mindfulness intervention compared to a educational program about FOG. FOG is a severe motor disturbance that prevents people from s...

What is the current status of trial NCT05923229?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2023-06-07. Estimated completion is 2024-04-26.

What conditions does trial NCT05923229 study?

This clinical trial studies the following conditions: Parkinson Disease, Mindfulness.

What interventions are being tested in trial NCT05923229?

The interventions under investigation include: Mindfulness Based Walking Therapy (MBWT) (BEHAVIORAL), Freezing of Gait (FOG) Education (OTHER).

Who is sponsoring clinical trial NCT05923229?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05923229 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05923229's enrollment target sits among peer trials

24 232nd of 297 higher than 61 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05923229, the US trial registry maintained by the National Library of Medicine. NCT05923229 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.